ETS2 and inflammatory bowel disease: In the adaptive immune response, ETS2 is linked to the differentiation of T helper cells, particularly Th1 and Th17 subsets, which are known to be key drivers of intestinal inflammation in IBD.[29] The overactivation of these immune pathways leads to a persistent inflammatory state, contributing to mucosal injury and disease progression.[30]